ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.59
-0.12%
US Tech 100
20,280.40
0.08%
S&P 500
5,987.37
0.30%
US Dollar vs CAD
1.41086
0.18%
Bitcoin
93,347.46
0.30%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Australia
  5. ASX
  6. Abundant Produce Limited (ABT)

  7. Abundant Produce Limited (ABT) News

ABT

Abundant Produce (ABT)

Abundant Produce Limited
Date:
Sort by:
 Showing the most relevant articles for your search:ASX:ABT
DateTimeSourceHeadlineSymbolCompany
01/09/20175:26AMNewspaperAbundant Produce Limited Show Promising GrowthASX:ABTAbundant Produce Limited
10/27/20098:58AMDow Jones NewsUPDATE: Hospira 3Q Profit Jumps 42%; EPS View RaisedTSXV:ABTAbbott Laboratories
10/26/20093:02PMDow Jones NewsEU Committee To Size Up Abbott, Solvay Cholesterol DrugsTSXV:ABTAbbott Laboratories
10/19/20093:08PMDow Jones NewsFDA Investigating Medical Device Power CordsTSXV:ABTAbbott Laboratories
10/14/200910:21AMDow Jones News2nd UPDATE: Abbott Labs 3Q Net Up 36%, Boost '09 Earns ViewTSXV:ABTAbbott Laboratories
10/14/20099:31AMDow Jones NewsAbbott Laboratories Leads Drug Stocks HigherTSXV:ABTAbbott Laboratories
10/14/20098:22AMDow Jones NewsUPDATE: Abbott Labs 3Q Net Up 36%, Boost '09 Earns ViewTSXV:ABTAbbott Laboratories
10/01/200912:22PMDow Jones NewsHospira Learning Valuable Lessons In European Biosimilar MarketTSXV:ABTAbbott Laboratories
09/29/20093:41PMDow Jones NewsMARKET SNAPSHOT: U.S. Stock Market Could Bask In More M&ATSXV:ABTAbbott Laboratories
09/29/20092:43PMDow Jones NewsMARKET SNAPSHOT: U.S. Stock Market Could Bask In More M&ATSXV:ABTAbbott Laboratories
09/29/20091:14PMDow Jones NewsMARKET SNAPSHOT: U.S. Stock Market Could Bask In More M&ATSXV:ABTAbbott Laboratories
09/29/200912:58PMDow Jones NewsCORRECT: FOCUS: BASF, Other Chemical Cos Targeting AsiaTSXV:ABTAbbott Laboratories
09/29/200912:05PMDow Jones NewsFOCUS: BASF, Other Chemical Cos Targeting Asia For GrowthTSXV:ABTAbbott Laboratories
09/29/20091:00AMDow Jones NewsFOCUS: Solvay Plans New Life As Chemicals, Plastics PlayTSXV:ABTAbbott Laboratories
09/28/20092:25PMDow Jones NewsUPDATE: Abbott Continues Acquisition Streak With Solvay DealTSXV:ABTAbbott Laboratories
09/28/20091:02PMDow Jones NewsAbbott Continues Acquisition Streak With Solvay DealTSXV:ABTAbbott Laboratories
09/28/200912:01PMDow Jones NewsAbbott Looks To Solvay To Help Solve Its Humira DependenceTSXV:ABTAbbott Laboratories
09/28/200911:23AMDow Jones NewsFOCUS: Solvay Plans New Life As Chemicals, Plastics PlayTSXV:ABTAbbott Laboratories
09/28/20099:03AMDow Jones News5th UPDATE:Solvay Sells Pharma Operations To Abbott For EUR4.5 Billion CashTSXV:ABTAbbott Laboratories
09/28/20094:50AMDow Jones NewsSolvay CEO Sees No New Acquisition Before Closing Pharma SaleTSXV:ABTAbbott Laboratories
09/28/20093:39AMDow Jones News4th UPDATE:Solvay Sells Pharma Operations To Abbott For EUR4.5 Billion CashTSXV:ABTAbbott Laboratories
09/28/20092:57AMDow Jones News3rd UPDATE: Solvay Sells Pharma Operations To Abbott For EUR4.5 Billion CashTSXV:ABTAbbott Laboratories
09/28/20092:02AMDow Jones News2nd UPDATE: Solvay Sells Pharma Unit To Abbott For EUR5.2 BillionTSXV:ABTAbbott Laboratories
09/28/20091:17AMDow Jones NewsUPDATE: Solvay Sells Pharma Unit To Abbott For EUR5.2 BillionTSXV:ABTAbbott Laboratories
09/28/200912:41AMDow Jones NewsSolvay Sells Pharma Unit To Abbott Laboratories For EUR5.2 BillionTSXV:ABTAbbott Laboratories
09/27/20099:58AMDow Jones NewsWSJ: Abbot Close To Announcing Deal For Solvay Pharma UnitTSXV:ABTAbbott Laboratories
09/24/20093:26PMDow Jones NewsAbbott Labs To Pay Church & Dwight $27 Million In Patent SettlementTSXV:ABTAbbott Laboratories
09/24/20093:01PMDow Jones NewsCORRECT: Church & Dwight: Abbott Labs To Pay Company $27 MillionTSXV:ABTAbbott Laboratories
09/23/20096:09PMDow Jones News2nd UPDATE:Abbott Stent Tops Boston Sci Devices In 2 StudiesTSXV:ABTAbbott Laboratories
09/23/20095:23PMDow Jones NewsStudy Shows 2-Year Benefits For Stent-Guiding SystemTSXV:ABTAbbott Laboratories
 Showing the most relevant articles for your search:ASX:ABT

Your Recent History

NASDAQ
AVXL
Anavex Life Sciences
USOTC
GDVM
Global Developments (PK)
USOTC
GNCP
GNCC Capital (CE)
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
AABB
Asia Broadband (PK)
COIN
SHIBUSD
SHIBA INU
USOTC
RDAR
Raadr (PK)
USOTC
NLST
Netlist (QB)
USOTC
SPZI
Spooz (PK)
USOTC
ASII
Accredited Solutions (PK)
NASDAQ
QUBT
Quantum Computing
NASDAQ
SMCI
Super Micro Computer
NASDAQ
RNAZ
TransCode Therapeutics
USOTC
CGAC
Code Green Apparel (PK)
NASDAQ
FCEL
FuelCell Energy
USOTC
CLNV
Clean Vision (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for North American Extreme

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $4354.20.64 only $1741.68